Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 116,129 | 113,892 | 115,791 | 122,372 | 97,108 |
| Operating Income | -116,129 | -113,892 | -115,791 | -122,372 | -97,108 |
| Interest Expense | 3,194 | 2,904 | 94 | 0 | 0 |
| Other Income | 7,368 | 8,755 | 5,028 | 7,011 | 7,566 |
| Pre-tax Income | -111,955 | -108,041 | -110,857 | -115,361 | -89,542 |
| Net Income Continuous | -111,955 | -108,041 | -110,857 | -115,361 | -89,542 |
| Net Income | $-111,955 | $-108,041 | $-110,857 | $-115,361 | $-89,542 |
| EPS Basic Total Ops | -0.69 | -0.76 | -0.97 | -1.05 | -0.90 |
| EPS Basic Continuous Ops | -0.69 | -0.76 | -0.97 | -1.05 | -0.90 |
| EPS Diluted Total Ops | -0.69 | -0.76 | -0.97 | -1.05 | -0.90 |
| EPS Diluted Continuous Ops | -0.69 | -0.76 | -0.97 | -1.05 | -0.90 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.76 | -0.97 | -1.05 | -0.88 |
| EBITDA(a) | $-115,996 | $-113,737 | $-115,751 | $-122,486 | $-97,494 |